MECHANISM OF ACTION OF PSORALENS - ISOBOLOGRAM ANALYSIS REVEALS THAT ULTRAVIOLET-LIGHT POTENTIATION OF PSORALEN ACTION IS NOT ADDITIVE BUT SYNERGISTIC

被引:14
|
作者
YURKOW, EJ [1 ]
LASKIN, JD [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT ENVIRONM & COMMUNITY MED,PISCATAWAY,NJ 08854
关键词
D O I
10.1007/BF00685118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The combination of psoralens and ultraviolet light (UVA, 320-400 nm), referred to as PUVA, inhibits proliferation of a variety of cell types. In the present studies, we used S-180 cells to investigate the mechanism underlying the antiproliferative actions of PUVA. We found that inhibition of growth of S-180 cells by PUVA was dependent on the concentration of psoralen as well as the dose of UVA light. Neither the psoralens nor UVA light by themselves inhibited cell growth. Several clinically important psoralen analogs inhibited cell growth. The potent phototoxin 4,5',8-trimethylpsoralen was the most active psoralen analog tested, followed by 5-methoxypsoralen and 8-methoxypsoralen. The angular furocoumarin, 5-methylangelicin, was the least active inhibitor of growth. Multivariate (isobologram) analysis of the growth-inhibition curves revealed that combinations of psoralens and UVA light were not simply additive but synergistic. Similar results were observed when inhibition of DNA synthesis was used as an endpoint for the biological effects of PUVA. These studies are the first to demonstrate that psoralens and UVA light act synergistically. Our results suggest that the synergism between the psoralens and UVA light may be an important property of PUVA that contributes to its therapeutic efficacy in proliferative diseases.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [31] ACTION SPECTRA FOR ULTRAVIOLET-LIGHT INACTIVATION OF SYSTEMS CONTAINING 5-BROMOURACIL-SUBSTITUTED DEOXYRIBONUCLEIC ACID .2. BACTERIOPHAGE T4
    SETLOW, R
    BOYCE, R
    BIOCHIMICA ET BIOPHYSICA ACTA, 1963, 68 (03) : 455 - &
  • [32] INHIBITION OF INTERFERON-PRODUCTION AND ANTI-VIRAL ACTION IN MOUSE CELLS BY 4,5',8-TRIMETHYLPSORALEN ACTIVATED WITH NEAR ULTRAVIOLET-LIGHT
    SAKAGUCHI, AY
    STEVENSON, D
    GORDON, I
    ARCHIVES OF VIROLOGY, 1980, 63 (01) : 69 - 74
  • [33] Whole transcriptome analysis of ovarian cancer cells reveals the mechanism of action for a potent organometallic anticancer agent
    Hearn, Jessica M.
    Romero-Canelon, Isolda
    Ying, Fu
    Wild, David L.
    Sadler, Peter J.
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Single-cell transcriptomic analysis reveals insights into the mechanism of action of Granulocyte-monocyte apheresis
    Kioroglou, D.
    Cabriada, J. L.
    Martinez Marigorta, U.
    Rodriguez-Lago, I.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I385 - I385
  • [36] DIFFERENTIAL PROTEOMIC ANALYSIS REVEALS THE ACTION MECHANISM OF ESTROGEN RECEPTOR β-MEDIATED ANTIOXIDANT ACTIVITIES IN A549 CELLS
    Lee, Hui-Ping
    Hsaio, Yi-Min
    Chen, Shu-Hui
    Tsai, Mei-Ling
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 227 - 227
  • [37] Comparative Proteomics Analysis Reveals Unique Early Signaling Response of Saccharomyces cerevisiae to Oxidants with Different Mechanism of Action
    Pandey, Prajita
    Zaman, Khadiza
    Prokai, Laszlo
    Shulaev, Vladimir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 17
  • [38] PROTECTION AGAINST LONG ULTRAVIOLET AND-OR VISIBLE LIGHT WITH TOPICAL DIHYDROXYACETONE - IMPLICATIONS FOR MECHANISM OF ACTION OF SUNSCREEN COMBINATION, DIHYDROXYACETONE-NAPHTHOQUINONE
    FUSARO, RM
    JOHNSON, JA
    DERMATOLOGICA, 1975, 150 (06): : 346 - 351
  • [39] Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection
    Noh, Heeju
    Shoemaker, Jason E.
    Gunawan, Rudiyanto
    NUCLEIC ACIDS RESEARCH, 2018, 46 (06)
  • [40] Network pharmacology-based analysis reveals the putative action mechanism of polygonum cuspidatum against COVID-19
    Zhao, Jun
    Pan, Boyu
    Xia, Yafei
    Liu, Liren
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (05): : 1852 - +